⌘K

Login Start Free

Home/Filings/4/0000899243-21-006400

4//SEC Filing

Sachs Jessica 4

Accession 0000899243-21-006400

CIK 0001622229other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 8:11 PM ET

Size

5.5 KB

Accession

0000899243-21-006400

Insider Transaction Report

Form 4

Period: 2021-02-10

Cogent Biosciences, Inc.COGT

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2021-02-10+126,500→ 126,500 total
Exercise: $10.17Exp: 2031-02-10→ Common Stock (126,500 underlying)

Footnotes (1)

[F1]This stock option shall vest in equal monthly installments over a four year period.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1

filerCIK 0001782545

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 8:11 PM ET
Size: 5.5 KB

View on SEC.gov